The landscape of global healthcare is currently facing a seismic shift. In recent weeks, a surge of commentary from high-profile industry leaders has emerged, with many discussions centred on the global funding crisis and its impact. These “big-hitters”...
Leaders in emerging markets are under pressure. Economies are strained. Geopolitical tension is rising. Growth must be sustained. Yet policy debates often miss one core driver of national performance: health. In fact, healthcare investment drives growth by improving...
South Africa is currently bracing for the most significant paradigm shift in its HIV response in over a decade. The national health authority has officially approved long-acting injectable pre-exposure prophylaxis (PrEP). There are plans to roll it out across the...
A pioneering microneedle patch, designed to dissolve upon contact with the eye, could soon replace inefficient traditional eye drops. Developed by a researcher at the University of the Witwatersrand (Wits), this innovative microneedle eyedrop delivery system holds the...
In a decision that could fundamentally reshape the fight against HIV, the US Food and Drug Administration (FDA) has given its approval to Gilead Sciences’ lenacapavir, a groundbreaking twice-yearly injection for preventing HIV infection in adults and...
